AlphaGrep UK
RMD icon

AlphaGrep UK’s ResMed RMD Stock Holding History

AlphaGrep UK’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$281K Sell
1,269
-1,525
-55% -$333K 0.08% 527
2026
Q2 		$544K Buy
2,794
+191
+7% +$39.6K 0.16% 199
2026
Q1 		$584K Buy
2,603
+189
+8% +$47.1K 0.17% 171
2025
Q4 		$581K Buy
+2,414
New +$617K 0.19% 162

Other funds holding RMD

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

AlphaGrep UK's RMD Position: Q3 2026 in Review

AlphaGrep UK reduced its ResMed (RMD) stake by 55% in Q3 2026, selling an estimated $333K and leaving 1,269 shares worth $281K. The position accounts for 0.08% of the portfolio, ranked #527.

AlphaGrep UK first reported a position in RMD in Q4 2025 and has held it in 4 quarters since. The position peaked at $584K in Q1 2026. 741 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • AlphaGrep UK held 1,269 shares of ResMed worth $281K as of Q3 2026.
  • AlphaGrep UK sold 1,525 ResMed shares in Q3 2026, an estimated $333K.
  • ResMed made up 0.08% of AlphaGrep UK's portfolio in Q3 2026, its #527 holding.
  • AlphaGrep UK first reported a position in ResMed in Q4 2025 and has held it in 4 quarters since.
  • AlphaGrep UK's ResMed position peaked at $584K in Q1 2026.
  • 741 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.